INIS
patients
100%
cancer
100%
infusion
100%
adenosine
100%
side effects
62%
doses
37%
symptoms
12%
safety
12%
administration
12%
toxicity
12%
losses
12%
weight
12%
performance
12%
fatigue
12%
chest
12%
ischemia
12%
world health organization
12%
anorexia
12%
breath
12%
Keyphrases
Home Setting
100%
Adenosine Triphosphate
100%
Terminal Illness
100%
Supportive Care
14%
High Dose
14%
Treatment Options
14%
Medical Treatment
14%
Life Expectancy
14%
Weight Loss
14%
Dyspnea
14%
World Health Organization
14%
Performance Status
14%
Organizational Performance
14%
Cardiac Disease
14%
Chest Discomfort
14%
Patients with Cancer
14%
Cardiac Ischemia
14%
Maximum Tolerated Dose
14%
National Cancer Institute
14%
Common Toxicity Criteria
14%
Anorexia
14%
Deep Breath
14%
Infusion Rate
14%
Nursing and Health Professions
Infusion
100%
Adenosine Triphosphate
100%
Malignant Neoplasm
100%
Side Effect
71%
Dyspnea
14%
Life Expectancy
14%
Drug Megadose
14%
Anorexia
14%
Low Drug Dose
14%
Combination Therapy
14%
Maximum Permissible Dose
14%
Infusion Rate
14%
Heart Muscle Ischemia
14%
Thorax Pain
14%
National Health Organization
14%
World Health Organization
14%
Medicine and Dentistry
Infusion
100%
Malignant Neoplasm
100%
Adenosine Triphosphate
100%
Side Effect
71%
Dyspnea
14%
Breathing
14%
Heart Muscle Ischemia
14%
Combination Therapy
14%
Drug Megadose
14%
Infusion Rate
14%
Anorexia
14%
Low Drug Dose
14%
Life Expectancy
14%
Supportive Care
14%
Disease
14%
Thorax Pain
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Adenosine Triphosphate
100%
Side Effect
71%
Dyspnea
14%
Anorexia
14%
Combination Therapy
14%
Life Expectancy
14%
Heart Muscle Ischemia
14%
Thorax Pain
14%